+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Biodefense Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biodefense Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Shigellosis - Pipeline Insight, 2025 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Influenza Vaccines Market Report 2023-2033 - Product Thumbnail Image

Influenza Vaccines Market Report 2023-2033

  • Report
  • October 2023
  • 192 Pages
  • Global
From
From
From
Digital Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines Market - Global Strategic Business Report

  • Report
  • March 2026
  • 274 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • March 2026
  • 485 Pages
  • Global
From
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • March 2026
  • 391 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • March 2026
  • 271 Pages
  • Global
From
Toxoid Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines Market - Global Strategic Business Report

  • Report
  • March 2026
  • 282 Pages
  • Global
From
From
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • March 2026
  • 182 Pages
  • Global
From
Loading Indicator